These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 32495019

  • 1. Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.
    Wienzek-Lischka S, Sawazki A, Ehrhardt H, Sachs UJ, Axt-Fliedner R, Bein G.
    Arch Gynecol Obstet; 2020 Aug; 302(2):355-363. PubMed ID: 32495019
    [Abstract] [Full Text] [Related]

  • 2. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
    Regan F, Lees CC, Jones B, Nicolaides KH, Wimalasundera RC, Mijovic A, Royal College of Obstetricians and Gynaecologists.
    BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
    [Abstract] [Full Text] [Related]

  • 3. New developments in fetal and neonatal alloimmune thrombocytopenia.
    Bussel JB, Vander Haar EL, Berkowitz RL.
    Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
    [Abstract] [Full Text] [Related]

  • 4. Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies.
    Winkelhorst D, Oepkes D, Lopriore E.
    Expert Rev Hematol; 2017 Aug; 10(8):729-737. PubMed ID: 28644735
    [Abstract] [Full Text] [Related]

  • 5. Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG.
    te Pas AB, Lopriore E, van den Akker ES, Oepkes D, Kanhai HH, Brand A, Walther FJ.
    Eur J Pediatr; 2007 Oct; 166(10):1057-63. PubMed ID: 17177068
    [Abstract] [Full Text] [Related]

  • 6. Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial.
    Paridaans NP, Kamphuis MM, Taune Wikman A, Tiblad E, Van den Akker ES, Lopriore E, Challis D, Westgren M, Oepkes D.
    Fetal Diagn Ther; 2015 Oct; 38(2):147-53. PubMed ID: 25896635
    [Abstract] [Full Text] [Related]

  • 7. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
    de Vos TW, Winkelhorst D, Árnadóttir V, van der Bom JG, Canals Surís C, Caram-Deelder C, Deschmann E, Haysom HE, Hverven HBC, Lozar Krivec J, McQuilten ZK, Muñiz-Diaz E, Nogués N, Oepkes D, Porcelijn L, van der Schoot CE, Saxonhouse M, Sola-Visner M, Tiblad E, Tiller H, Wood EM, Young V, Železnik M, de Haas M, Lopriore E.
    Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
    [Abstract] [Full Text] [Related]

  • 8. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J, Bengtsson J.
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [Abstract] [Full Text] [Related]

  • 9. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future.
    Serrarens-Janssen VM, Semmekrot BA, Novotny VM, Porcelijn L, Lotgering FK, Delemarre FM, Steegers EA.
    Obstet Gynecol Surv; 2008 Apr; 63(4):239-52. PubMed ID: 18348738
    [Abstract] [Full Text] [Related]

  • 10. Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review.
    Winkelhorst D, Murphy MF, Greinacher A, Shehata N, Bakchoul T, Massey E, Baker J, Lieberman L, Tanael S, Hume H, Arnold DM, Baidya S, Bertrand G, Bussel J, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Ryan G.
    Blood; 2017 Mar 16; 129(11):1538-1547. PubMed ID: 28130210
    [Abstract] [Full Text] [Related]

  • 11. Lower-dose intravenous immunoglobulins for the treatment of fetal and neonatal alloimmune thrombocytopenia: a cohort study.
    Kamphuis M, Paridaans N, Winkelhorst D, Wikman A, Tiblad E, Lopriore E, Westgren M, Oepkes D.
    Transfusion; 2016 Sep 16; 56(9):2308-13. PubMed ID: 27383293
    [Abstract] [Full Text] [Related]

  • 12. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
    Lakkaraja M, Berkowitz RL, Vinograd CA, Manotas KC, Jin JC, Ferd P, Gabor J, Wissert M, McFarland JG, Bussel JB.
    Am J Obstet Gynecol; 2016 Oct 16; 215(4):471.e1-9. PubMed ID: 27131591
    [Abstract] [Full Text] [Related]

  • 13. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.
    Cook TJ, Qiu CC, Dickinson JE.
    Aust N Z J Obstet Gynaecol; 2012 Aug 16; 52(4):321-6. PubMed ID: 22510050
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of gradual conversion to a less invasive therapeutic strategy for pregnant women with alloimmune thrombocytopenia in the fetus for prevention of intracranial hemorrhage].
    Radder CM, Kanhai HH, de Beaufort AJ, Klumper FJ, Brand A.
    Ned Tijdschr Geneeskd; 2000 Oct 14; 144(42):2015-8. PubMed ID: 11072521
    [Abstract] [Full Text] [Related]

  • 15. Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.
    Van Der Lugt NM, Kamphuis MM, Paridaans NP, Figee A, Oepkes D, Walther FJ, Lopriore E.
    Blood Transfus; 2015 Jan 14; 13(1):66-71. PubMed ID: 24960663
    [Abstract] [Full Text] [Related]

  • 16. Management and Neonatal Outcomes of Pregnancies with Fetal/Neonatal Alloimmune Thrombocytopenia: A Single-Center Retrospective Cohort Study.
    Ronzoni S, Keunen J, Shah PS, Kelly EN, Windrim R, Seaward PG, Ryan G.
    Fetal Diagn Ther; 2019 Jan 14; 45(2):85-93. PubMed ID: 29669341
    [Abstract] [Full Text] [Related]

  • 17. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.
    Ernstsen SL, Ahlen MT, Johansen T, Bertelsen EL, Kjeldsen-Kragh J, Tiller H.
    Am J Obstet Gynecol; 2022 Sep 14; 227(3):506.e1-506.e12. PubMed ID: 35500612
    [Abstract] [Full Text] [Related]

  • 18. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia.
    Matusiak K, Patriquin CJ, Deniz S, Dzaja N, Smith JW, Wang G, Nazy I, Kelton JG, Arnold DM.
    Transfusion; 2022 Nov 14; 62(11):2213-2222. PubMed ID: 36239096
    [Abstract] [Full Text] [Related]

  • 19. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
    Uhrynowska ME, Dębska M, Guz K, Orzińska A, Wróbel A, Maślanka K, Dębski R, Brojer E.
    Ginekol Pol; 2015 Jan 14; 86(1):62-6. PubMed ID: 25775877
    [Abstract] [Full Text] [Related]

  • 20. [Thirty years of platelet immunology in fetal and neonatal alloimmune thrombocytopenia management, current situation].
    Petermann R.
    Transfus Clin Biol; 2017 Sep 14; 24(3):166-171. PubMed ID: 28673503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.